Cholera Ripping Through Yemen

More than 100,000 cases of the bacterial disease have been reported in the war torn country.

Written byDiana Kwon
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A healthcare worker treating an infant in YemenUNICEFYemen, a country ravaged by two years of intense conflict, is experiencing a rapidly spreading cholera epidemic. According to the World Health Organization (WHO) and UNICEF, as of Wednesday (June 7) the number of suspected cases of the acute, infectious diarrheal illness has reached 101,820, with 791 deaths. Forty six percent of the reported cases are in children under age 15, and 33 percent of the fatalities have been in people over the age of 60.

“I personally received 180 cases in one day,” Mohammed Zaid, a doctor who works at a hospital in Sana’a, Yemen, tells the Guardian. “People are left lying in the corridors, and in some cases we are having to put six children in one bed.”

Cholera typically spreads through contaminated food and water. Without treatment, people with severe cases can die from dehydration within hours. Though the illness can be effectively treated by rapidly replenishing lost fluids and salts, the ongoing war has devastated Yemen’s health, water, and sanitation systems, making it difficult to deliver aid to patients.

“Two years of war have plunged the country into one of the world’s worst humanitarian crises and put Yemen at risk of famine,” Sajjad Mohammed Sajid, Oxfam's Yemen ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Diana is a freelance science journalist who covers the life sciences, health, and academic life. She’s a regular contributor to The Scientist and her work has appeared in several other publications, including Scientific American, Knowable, and Quanta. Diana was a former intern at The Scientist and she holds a master’s degree in neuroscience from McGill University. She’s currently based in Berlin, Germany.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies